Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
International Journal of Stroke (IJS) recently shared a post on X:
”Just Accepted!
Study finds hemorrhagic transformation was associated with onset-to-imaging time and presence of severe hypoperfusion. No interaction found between time and severe hypoperfusion.”
Read the full article here.
A new study is reinforcing the importance of timely management of stroke in an article ‘Association between Time and Severe Hypoperfusion with Risk of Hemorrhagic Transformation in Stroke Patients’ by Umberto Pensato et al., published in International Journal of Stroke (IJS).
Emerging evidence highlights that both severe hypoperfusion and time spent in a hypoperfused state contribute to the risk of parenchymal hematoma (PH) in ischemic stroke.
A recent analysis confirms that while each factor independently increases the likelihood of hemorrhagic transformation (HT), their interaction was not statistically significant.
These findings suggest that the risk of HT is influenced by distinct pathways related to hypoperfusion severity and duration.
Identifying patients with a “leaky core”—those with severely compromised blood-brain barriers—could enhance patient selection for targeted interventions!

Hemostasis Today, your daily update on scientific advancements in the World of Stroke.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?